Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.

Rasmussen, K; Czachura, J F; Stockton, M E; Howbert, J J

Rasmussen, K; Czachura, J F; Stockton, M E; Howbert, J J.

Affiliation

Rasmussen K; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana.

J Pharmacol Exp Ther ; 264(1): 480-8, 1993 Jan.

Article in En | MEDLINE | ID: mdl-8423546

Subject(s)

Cholecystokinin/antagonists & inhibitors; Dopamine/physiology; Mesencephalon/drug effects; Neurons/drug effects; Phenylurea Compounds; Pyrazoles; Animals; Benzodiazepinones/pharmacology; Cholecystokinin/pharmacology; Electrophysiology; Male; Mesencephalon/cytology; Mesencephalon/physiology; Neurons/physiology; Rats; Rats, Sprague-Dawley

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyrazoles / Cholecystokinin / Mesencephalon / Dopamine / Neurons Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 1993 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links